Gynecology & Obstetrics (all articles)
ASCO Guideline Update: Estrogen and Progesterone Receptor Testing in Breast Cancer
14 Jan, 2020 | 00:27h | UTCNews Release: Updated Breast Cancer Guideline Refines Testing to Better Identify Patients Likely to Benefit from Treatment – College of American Pathologists (free)
Pregnancy-related Cardiovascular risk Indicators: Primary Care Approach to Postpartum Management and Prevention of Future Disease
14 Jan, 2020 | 00:07h | UTC
Review: The Use of Medication in Pregnancy
14 Jan, 2020 | 00:09h | UTCThe Use of Medication in Pregnancy – Deutsches Ärzteblatt international (free)
[Abstract Only] Meta-Analysis: Uterine Balloon Tamponade for the Treatment of Postpartum Hemorrhage
12 Jan, 2020 | 21:16h | UTCUterine Balloon Tamponade for the Treatment of Postpartum Hemorrhage: a Systematic Review and Meta-Analysis – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)
Commentaries: Technique is almost 86 percent effective in preventing maternal death from hemorrhaging – Massachusetts General Hospital (free) AND Uterine Balloon Tamponade for Postpartum Bleeding Seems Safe – Physician’s Briefing (free)
Meta-Analysis: The Timing of Urinary Catheter Removal after Gynecologic Surgery
12 Jan, 2020 | 21:00h | UTC
Study: Surgical Results of Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
12 Jan, 2020 | 20:47h | UTCBreast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary: Despite effective therapy, US rate of breast conservation lower than other countries – Brigham and Women’s Hospital (free)
Related Commentary on Twitter
Neoadjuvant #chemotherapy makes breast conservation possible in half of patients with stages II to III TNBC who would have otherwise required #mastectomy https://t.co/ftcVdmj9RL @MehraGolshan
— JAMA Surgery (@JAMASurgery) January 8, 2020
[Abstract Only] Study: Sustained Weight Loss Linked to Lower Risk of Breast Cancer
8 Jan, 2020 | 22:20h | UTCSustained weight loss and risk of breast cancer in women ≥50 years: a pooled analysis of prospective data – JNCI: Journal of the National Cancer Institute (link to abstract – $ for full-text)
Commentaries: Large study links sustained weight loss to reduced breast cancer risk – American Cancer Society (free) AND Weight loss linked to lower chance of getting breast cancer for women over 50 – NHS Choices (free) AND Study Links Sustained Weight Loss to Reduced Breast Cancer Risk – The ASCO Post (free)
Randomized Trial: Long-term Aromatase Inhibitor Prevents Breast Cancer in High-risk Postmenopausal Women
8 Jan, 2020 | 21:48h | UTCCommentaries: IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women – Queen Mary, University of London (free) AND Drug that prevents half of breast cancers carries on working – BBC (free) AND Long-Term Results of IBIS-II: Anastrozole for Breast Cancer Prevention – The ASCO Post (free)
Study: Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years
8 Jan, 2020 | 08:44h | UTCPrevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States – JAMA Internal Medicine (free for a limited period)
Commentaries: Unnecessary Bimanual Pelvic Examinations and Papanicolaou Testing in Adolescents and Young Women—Learning How to Unlearn – JAMA Internal Medicine (free for a limited period) AND Young women still may be getting unnecessary pelvic exams – University of California – San Francisco (free) AND Many young women get unnecessary pelvic exams – Reuters (free)
[Abstract Only] Randomized Trial: Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
8 Jan, 2020 | 00:51h | UTCCommentaries: SABCS 2019: Adding Tucatinib to Capecitabine/Trastuzumab Improved Survival for Patients With Advanced HER2-Positive Breast Cancer – The ASCO Post (free) AND HER2CLIMB and DESTINY-Breast01 Findings in Heavily Pretreated HER2-positive MBC – ESMO (free)
[Abstract Only] Randomized Trial: Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
8 Jan, 2020 | 00:51h | UTCOverall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Targeted therapy drug helps women with aggressive breast cancer live longer – University of California (free) AND Overall Survival With the Addition of Ribociclib to Fulvestrant in Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer: MONALEESA-3 – The ASCO Post (free)
Study: Google Artificial Intelligence Algorithm Improves Accuracy of Breast Cancer Detection in Mammography
5 Jan, 2020 | 14:14h | UTCInternational evaluation of an AI system for breast cancer screening – Nature (free link via STAT)
Commentaries: AI shows promise for breast cancer screening – Nature (free) AND Google AI tool can pinpoint breast cancer better than clinicians, new study suggests – STAT (free) AND Artificial intelligence could help to spot breast cancer – Imperial College London (free) AND AI can now outperform doctors at detecting breast cancer. Here’s why it won’t replace them – Vox (free) AND A.I. Is Learning to Read Mammograms – The New York Times (10 articles per month are free) AND Study finds Google system could improve breast cancer detection – Reuters (free)
Another Observational Study Suggests One Dose of HPV Vaccine may be Enough
5 Jan, 2020 | 13:25h | UTCCommentaries: One dose of HPV vaccine may prevent infection from cancer-causing virus, study reveals – News Medical (free) AND Just 1 dose of the HPV vaccine may protect against infection, new study suggests – CNN (free)
Related: Systematic Review: Comparison of Different HPV Vaccine Types and Dose Schedules for Prevention of HPV‐related Disease in Females and Males – Cochrane Library (free) AND Large Observational Study Suggests One Dose of HPV Vaccine May Be as Effective as Three (free)
[Abstract Only] Randomized Trial: Accelerated Partial Breast Irradiation vs. Whole-breast Irradiation After Breast-conserving Surgery for Early-stage Breast Cancer
5 Jan, 2020 | 13:05h | UTCLong-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial – The Lancet (link to abstract – $ for full-text)
Related Commentary on Twitter
PRESS RELEASE: Accelerated Partial Breast Irradiation Although Close was Not Equivalent to Whole-breast Irradiation to Control Ipsilateral Breast Tumor Recurrence https://t.co/mCvuC5aeag #breastcancer pic.twitter.com/KRXAAtAjbj
— NRG Oncology (@NRGonc) December 6, 2019
[Abstract Only] Randomized Trial: External Beam Accelerated Partial Breast Irradiation vs. Whole Breast Irradiation after Breast Conserving Surgery in Women with Ductal Carcinoma in Situ and Node-negative Breast Cancer
5 Jan, 2020 | 13:08h | UTCExternal beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial – The Lancet (link to abstract – $ for full-text)
Commentary: Results mixed for twice-daily APBI in early breast cancer – MedicalXpress (free)
Related Commentary on Twitter
NEW: External beam accelerated partial breast irradiation was non-inferior to whole breast irradiation in preventing ipsilateral breast tumour recurrence: finding from the RAPID randomised controlled trial https://t.co/4aexxXC8Vg pic.twitter.com/JMa0jUWY1X
— The Lancet (@TheLancet) December 6, 2019
NICE Guideline: Menopause
6 Dec, 2019 | 10:50h | UTCMenopause: diagnosis and management – National Institute for Health and Care Excellence (free)
ASH Guideline: Prevention of Venous Thromboembolism in Surgical Hospitalized Patients
5 Dec, 2019 | 11:29h | UTCRelated: European guidelines on perioperative venous thromboembolism prophylaxis – European Journal of Anaesthesiology (comprehensive resource on the subject) AND American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Prophylaxis for Hospitalized and Nonhospitalized Medical Patients (free)
Cohort Study: Maternal Diabetes During Pregnancy Linked to Early Onset of Cardiovascular Disease in Offspring
5 Dec, 2019 | 10:45h | UTCCommentaries: Link between diabetes in mothers and heart disease in children – OnMedica (free) AND Preventing and treating diabetes in women of childbearing age could reduce heart disease risk in the next generation – The BMJ Opinion (free)
[Abstract Only] Cohort Study: Hair Dye and Chemical Straightener Associated with Increased Risk of Breast Cancer
5 Dec, 2019 | 07:49h | UTCHair dye and chemical straightener use and breast cancer risk in a large US population of black and white women – International Journal of Cancer (link to abstract – $ for full-text)
Commentaries: Permanent hair dye and straighteners may increase breast cancer risk – NIH News Releases (free) AND Hair Dyes And Straighteners Linked To Higher Cancer Risk, Especially For Black Women – NPR (free)
Randomized Trial: Synchronous vs. Sequential Chemo-radiotherapy in Patients with Early Stage Breast Cancer
4 Dec, 2019 | 08:17h | UTC
AAP Policy Statement: Emergency Contraception
3 Dec, 2019 | 08:15h | UTCEmergency Contraception – Pediatrics (free)
Related: Committee Opinion No 707: Access to Emergency Contraception – American College of Obstetricians and Gynecologists (free) AND Interventions for emergency contraception – Cochrane Library (free)
[Abstract Only] Randomized Trial: Supplemental MRI Screening vs. Usual Care with Mammography Only for Women with Extremely Dense Breast Tissue
28 Nov, 2019 | 10:39h | UTCSupplemental MRI Screening for Women with Extremely Dense Breast Tissue – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Does MRI Screening Benefit Women With Extremely Dense Breasts? – U.S. News (free) AND Mixed Results With Mammo Plus MRI Screening – MedPage Today (free)
“The benefits need to be carefully weighed against the harms, as MRI examination is more expensive, and it requires the injection of a contrast agent into the body. MRI will also detect abnormalities that later turn out not to be breast cancer after all” (from U.S News)
Related Commentary on Twitter
In this randomized trial, women with extremely dense breast tissue were invited to undergo MRI screening or received only mammography during a 2-year screening period. https://t.co/tZmcappO00
— NEJM (@NEJM) November 27, 2019
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
27 Nov, 2019 | 08:19h | UTCCommentary: European guidelines for breast cancer screening differ from U.S. recommendations – ACP Internist (free)
Related: ACP Guideline: Screening for Breast Cancer in Average-Risk Women (other guidelines and commentaries on the subject)
Review: Cardiomyopathy and Pregnancy
27 Nov, 2019 | 07:39h | UTCCardiomyopathy and pregnancy – Heart (free)
Related: Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy – European Journal of Heart Failure (free) AND Peripartum Cardiomyopathy – Circulation (free) AND Practical management of peripartum cardiomyopathy – Korean Journal of Internal Medicine (free) AND State of the Art Review: Peripartum cardiomyopathy – The BMJ (free)
Randomized Trial: Injectable 17-α-hydroxyprogesterone Not Effective for the Prevention of Recurrent Preterm Birth
24 Nov, 2019 | 20:59h | UTCCommentary: Advice to pull a drug used to prevent premature birth sparks controversy – News Medical (free) AND Unexpected Findings in Confirmatory Trial of Preterm Birth Drug – MedPage Today (free registration required)
Related Study: A Randomized Trial of Progesterone in Women with Recurrent Miscarriages – New England Journal of Medicine (free)